Form SUPPL BROOKFIELD ASSET MANAGEM - search results

Related Title : - Form SUPPL BROOKFIELD ASSET MANAGEM Ref: https://www.streetinsider.com

The Cerealia agricultural trade platform will focus on the international trade of the world's largest wheat market, Russia

Minneapolis, November 10, 2020 (GLOBE NEWSWIRE) - KeyedIn, a leader in lean portfolio management, today announced that one of the world's largest global financial services firms has chosen KeyedIn as a Project Portfolio Management (PPM) solution for its growing Project Management Office (PMO) said Tim Short, Chief Revenue Officer at KeyedIn: "Our entire financial services business model is in disruption, and our PPM solution helps organizations advance organizational and market changes by prioritizing and then introducing the corporate initiatives with the greatest impact." “The selection of KeyedIn by another major financial services company is an assurance that our PPM solution is ideally suited for these organizations. KeyedIn will automate the entire project life cycle for this financial services client, from demand planning and portfolio management to project implementation and resource management KeyedIn provides a comprehensive solution PPM provides to its financial services clients, and enables them to: * Deliver strategic results with accurate forecasting: Financial services organizations require a strategic plan for people, investments and innovation. Using KeyedIn, clients can generate accurate resource forecasts against incoming demand and it helps them reach usage targets, model scenarios. Reporting budget against actual values ​​to improve resource demand planning * Get more value from project investments: KeyedIn helps financial services teams save time and money by managing projects, evaluating and prioritizing projects at the portfolio level and sharing costs between projects helps them clearly understand project benefits, costs and risks. It enables organizations not only to invest in the right projects from the start, however Also cut non-profit projects before investing too much in them * Ensure alignment across the organization: From C-suite all the way to the technical level, KeyedIn provides convenient access to reports, analyzes, insights and KPIs to ensure organizational compliance KeyedIn provides a flexible interface that enables custom views and access to Role Based Information * Manage Agile Work Patterns, Waterfall, and Custom Work Patterns: KeyedIn provides a unified platform for project portfolio management. Project implementation can be implemented in any number of integrated systems, such as Jira or Microsoft TFS, with all approvals, work and money tracking, and reporting At KeyedIn, to learn more about how financial services organizations benefit from KeyedIn, visit https: // www. Kiddincom / clients / financial services / about KeyedInKeyedIn helps organizations streamline business processes, improve performance and enhance results through innovative SaaS-based business solutions The company's flagship product, KeyedIn Projects , Is a cloud-based Project and Portfolio Management (PPM) solution that enables Project Management Offices (PMOs) and teams Integrated Services (ESOs) to increase productivity, reduce reporting costs and save operating expenses KeyedIn is headquartered in Minneapolis and has hundreds of clients around the world, including Walgreens Boots Alliance, Universal Electronics and OfficeDepot. For more information, visit KidenCom, or call At 866-662-6820 For more media information contact: Lisa Hendrickson, LCH Communications for KeyedIn lisa @lchcommictures com 516-767-8390

. . Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Magellan Health, Inc. . (NASDAQ: MGLN) to Centene Corporation for $ 95. 00 per share in cash is fair to Magellan's shareholders.

. . Government support and initiatives to increase sales of e-bikes would drive the global e-bike market. The Class III e-bike is valued as the fastest growing e-bike market in the world. New York, Dec. . 08, 2020 (GLOBE NEWSWIRE) - Report linker. com announces the release of the report "E-Bike Market by Class, Battery, Motor, Mode, Usage, Speed, and Region - Global Forecast to 2027" - https: // www. reportlinker. com / p05754128 /? utm_source = GNW class III e-bikes offer a potential solution for replacing cars to avoid traffic and reduce emissions. Therefore, the Class III e-bike market is expected to grow over the forecast period. Class III e-bikes are not currently available in the Asia-Pacific region. While Switzerland is the largest market for class III e-bikes in Europe, followed by Belgium and Italy. The North American region currently has limited distribution of Class III e-bikes, with only six states approving their operation. Class III e-bikes in Europe and North America have a minimum age limit of 16 years. Folding and fat tire e-bikes are valued as the fastest growing e-bike market worldwide. The collapsible e-bike is becoming a popular choice with near-urban commuters. Large conventional bicycle manufacturers are also bringing their e-bikes to the Indian market with the latest technology and innovative design. For example, Hero Cycle is presenting its e-bikes at Auto Expo 2020, which include a folding bike (Easy Step, a Straphanger) and an electric fat bike (Essentia). . Currently, the market for folded and fat tire e-bikes is limited in the Asia-Pacific, Europe and North America. However, we assume that the market for folded and fat tire e-bikes will be the fastest growing e-bike market worldwide during the forecast period. North America is expected to be the fastest growing market in the world. There is currently a minimal presence of e-bike manufacturers in the North American region, resulting in a limited market for e-bikes. However, the public awareness of e-bikes and the commitment / interest of traditional bike brands for e-bikes has led to an enthusiasm for e-bikes in the market. Pedego Electric Bikes and Trek Bicycle Corporation are the main manufacturers of e-bikes in North America. Therefore, North America is expected to be the fastest growing market over the forecast period. The breakdown of the primary respondents • By company: OEM - 70%, Tier 1 - 30% • By title: Director Level - 30%, C-Level Executives - 60%, Others - 10% • By region: Asia-Pacific - 50% %, Europe - 20%, North America - 30% The e-bike market is dominated by global players and includes several regional players. The main players in the e-bike industry Accell Group N. . V. . (Netherlands), Pon. Bicycle (USA), Merida Industry Co. . , GmbH. (China), Giant Manufacturing Co. . , GmbH. (Taiwan) and Yamaha Motor Corporation (Japan). The study includes an in-depth competitive analysis of these key players in the E-Bike market with their company profiles, a SWOT analysis of the top five companies, recent developments, and key market strategies. Research Report The report covers the E-Bike market by Class (Class I, Class II, Class III), Battery Type (Lithium Ion, Lithium Ion Polymer, Lead-Acid, etc.. ) and engine type (center, hub) from), mode (gas, pedal assistant), use (mountain / trekking, city / town, freight, other), speed (up to 25 km / h, 25-45 km / h) and Region (Asia Pacific, Europe, North America). Industry analysis and company profiles are also gathered in this report, highlighting emerging and high growth segments of this market, SWOT analysis, competitive landscape, competitive leadership mapping, and market dynamics (drivers, restraints, opportunities, & challenges). . Key Benefits of Buying the Report: The report will help the market leaders / new entrants in this market with information on the closest approximations of the sales figures for the whole E-Bike Market and its sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their companies and plan appropriate go-to-market strategies. The report also helps the stakeholders get the pulse of the market and informs them of key market drivers, restraints, challenges, and opportunities. Read the full report: https: // www. reportlinker. com / p05754128 /? utm_source = GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you can get all of the market research you need - instantly in one place. __________________________ CONTACT: Clare: clare @ reportlinker. com US: (339) -368-6001 Intl: 1 339-368-6001

Hedge Insurance Company (NASDAQ: PTVC b) the stock is about to trade with dividends in four days it will need to

The main companies covered by the Incontinence Care Products Market Research Report are Procter & Gamble, Kimberly Clark Corporation, Paul Hartmann AG, Confatec Inco, Wellspect HealthCare (Dentsply Sirona), Essity, Coloplast Corp, Ontex, Domtar Corporation, BD, Hollister Incorporated, among others Key Market Players Pune, November 10, 2020 (GLOBE NEWSWIRE) - The global incontinence care products market is projected to reach US $ 24 35 billion by 2026, at a compound annual growth rate of 69% by 2026, between 2019 and 2026 This is due to the increase in the number of elderly people and the spread of incontinence problems among them The market value of 14 US dollars 30 billion in 2018 The World Health Organization predicts that about 120 million people in China will be over 80 years by the end of 2050. From urinary incontinence problems, thus driving market trends for incontinence care products, Europe dominated the market with US $ 4 94 billion gained in 2018 due to increased demand for urine catheters. Industry development: * May 2019, along with growing demand for disposable incontinence treatment devices: Kimberly-Clark announced the launch of Poise UltraThin Active Collection, a range of pads and liners with wings for greater stability among women * November 2017: Essity introduced the new ConfioAir Breathable Technology that will be used in the manufacture of all the company's panties, panties, and other incontinence products * July 2019: Suominen Corporation launched the FIBRELLA Combo, providing excellent fluid management and softness of the top layer * March 2017: Announced The Hartmann Group announced the acquisition of & Gamble's Lindor in Spain and Portugal Lindor is a popular brand for adult incontinence products Request a copy of the research report: https: // www insights-com / quiry / request-sample-pdf / incontinence-care-products-market-101178 Government-backed outreach programs will help increase growth launch products New and advanced personal hygiene for incontinence disorders is a major factor driving the growth of the incontinence care products market in general.Furthermore, the increased awareness of incontinence products, supported by governments, is expected to increase the size of the incontinence device market in the forecast period regardless of This, the popularity of home care services and the presence of online retail stores and the e-commerce industry will also drive returns from the incontinence care products market in the coming years. Click here to get the short-term and long-term impact of COVID-19 on this market please visit: https: // www Wealth Insights com / industry-reports / incontinence-care-products-market-101178 The European market is dominated by the increase in the number of consumers who buy urinary catheters, geographically, Europe dominated the market with $ 4 The US gained 94 billion in 2018 due to the increased demand for urinary catheters, along with the increasing demand for disposable incontinence devices. Besides, the government that favors home care services and provides educational programs is also expected to help attract market revenue. Incontinence Devices to this Region On the other hand, the market in Asia Pacific is likely to witness robust growth due to the increase in disposable income of people, the increase in the number of elderly people, and the increased prevalence of incontinence in the region Quick Buy - Incontinence Care Products Market Research Report: https: // www visions fortune com / checkout-page / 101178 companies mainly focus on controlling the smell and the soft touch of their products. Manufacturers of the main incontinence devices market emphasize the introduction of new technologies to improve the quality of their products. The main goal of the players is to focus on factors such as odor control, soft touch and free traits. Leakage for incontinence care products The major sellers in the incontinence care products market include: * Procter & Gamble * Kimberly Clark Corporation * Paul Hartman E. Yeh Ji * Confatec Corporation * Wellspect HealthCare (Dentsply Sirona) * Essity * Coloplast Corp * Ontex * Domtar Corporation * BD * Hollister Incorporated Do you have any questions? Ask our experts: https: // www fortune insights com / quiry / talk-to-analyst / incontinence-care-products-market-101178 Market segmentation for incontinence care products: by product type • Non-absorbent such as Catheterso Slingso Drainage Bagso o Other stimulating devices • & Underwear and Briefs Collector's Briefs Drip & Protective Bed Pads & Guards by Gender Male • Female by Use • Reusable • Disposable by Distribution Channel • Corporate Sales • Retail Stores • Online Channels by Geography • North America) United States (X and Canada) • Europe (U such as Germany, France, Italy, Spain, Scandinavia, Rest of Europe) • Asia and the Pacific (Japan, China, India, Australia, Southeast Asia, Rest of Asia and the Pacific) • Latin America (Brazil, Mexico and the rest of Latin America) • The Middle East and Africa (SOUTH AFRICA, GCC, REST OF THE MIDDLE EAST & Africa) Get your personalized search report: https: // www e-products-market-101178 The secondary search was performed to obtain the following information: * Details such as revenue, market share, strategies, growth rate, product & rates by region / country for all companies specialties * Details related to prevalence, incidence, patient numbers, patient distribution, average Treatment price, etc. * Number of end-user facilities by region / country and average annual spending or equipment purchases by type of end-user facility * Number of procedures and average price of procedures * Replacement rate and prices for capital equipment * Market dynamics in relation to the market in focus - Drivers, restraints, trends, and opportunities * & technology market trends, new product developments and product pipeline Look at related reports: & Adult Diapers Market Share Industry Analysis, by Product Type (& Briefs for Underwear, & Pillows, & Bed Protectors & Dotting Collectors), by Gender (male and female) by distribution channel (institutional sales, retail) stores and online channels) and prediction Regional T, 2019-2026 Urinary Catheter Market Share & Industry Analysis, by Product (Indwelling Catheters, Intermittent Catheters, and External Catheters), by Application (Urinary Incontinence, BPH, Surgery, etc.), by gender (female) , Male), by end user (hospitals, age centers, etc.) and regional forecasts 2019-2026 Electrode Market Share under Neighborhood & Industry Analysis, by Type (Sector, Network, Depth, etc.) by Material (Platinum and Stainless Steel) By end user (hospitals, specialty clinics, etc.) and regional forecasts, 2019-2026 Immune thrombocytopenia (ITP) Market share of & Industry Analysis, by type (acute immune thrombocytopenia, chronic immune thrombocytopenia), by treatment (thrombopoietin receptor agonist, immunoglobulin) , Corticosteroids, and others), by distribution channel (hospital pharmacy, retail pharmacy, etc.) and regional outlook, 2019-2026 Backbone Devices Market Share & Industry Analysis, by Type Product (fusion devices (cervical devices, thoracic lumbar devices, interbody devices, and biological materials), non-fusion devices (vertebral decompression devices, artificial discs, dynamic fixation devices, etc.), stimulation devices) according to disease index (disc disease Degenerative, complex deformation, trauma, & fractures, and others), by the end user (Hospitals & Ambulatory Surge Who We Are: Fortune Business Insights ™ provides expert analysis of companies and accurate data, helping organizations of all sizes to make timely decisions We design Our goal is to empower our customers with a comprehensive intelligence of the market, and to give an accurate overview of the market in which they work.Our reports contain a unique combination of concrete insights and qualitative analysis to help companies achieve sustainable growth Our team of experienced analysts and consultants use tools And industry-leading research technologies to bring together comprehensive market studies interspersed with relevant data In Fortune Business Insights ™ we aim to entertain I Highlight the most profitable growth opportunities for our clients Therefore, we provide recommendations, making it easier for them to navigate through technological and market-related changes. Our advisory services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. Contact us: Fortune Business Insights ™ Pvt 308 Limited, Senior Leadership, Scan No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India Phone: US: 1424253 0390 UK: 44 2071 939123 Asia Pacific: 91744740 1245 Email: sales @ fortunebusinessinsightscom Fortune Business Insights ™ LinkedIn | Twitter | Press release for blogs: https: // www Insights Tharkum / Press release / Incontinence-Products-Market-9571

Health Media Network (HMN), a leading care and OOH media company, and Meredith Corporation (NYSE: MDP) today announced the first strategic alliance to roll out trusted Meredith content in doctors' offices across the country. The new Meredith Health Media Network Alliance enables advertisers to engage healthcare-focused consumers across all Meredith assets as well as HMN's fully addressable video networks that include the Women's and Men's Health Network, the Children and Family Network and the unique PetCare TV Network

SAN JOSE, CA, November 10, 2020 (GLOBE NEWSWIRE) - AnPac ​​Bio-Medical Science Co, Ltd. ("AnPac ​​Bio" or "The Company" or "We") (NASDAQ: ANPC), a biotech company operating In China and the United States, it announced today that the company has completed the FDA EUA- SARS-CoV-2 (COVID) -19) antibody verification test at the San Jose, California laboratory in November 2020 for the Roche Elecsys Anti Sars-COV-2 test, which is now Able to enter the commercial testing phase The company has also announced that COVID-19 antibody testing equipment has also completed its installation in the Philadelphia Lab. Anpac Bio has focused on developing and marketing COVID-19 testing products and services in both the US and China as COVID-19 cases continue to rise. 19 With no clear short-term and medium-term containment measures in sight, COVID-19 tests are likely to become long-term and widely required In addition, COVID-19 antibody testing is likely to become increasingly valuable as a measure of the potential effectiveness of COVID-19 vaccines, and in helping employers ensure office safety and productivity alongside AnPac ​​Bio's vision and goal of developing and delivering products. And new testing services, the company is fully committed to qualifying and marketing COVID-19 tests in both the United States and China The verification and marketing of COVID-19 antibody tests in the United States is a major milestone for AnPac ​​Bio, as this is the first commercial test in the United States from In addition to this, the company will also offer anti-COVID-19 antibody tests at the company’s laboratory in Philadelphia, where the COVID-19 antibody testing equipment has been installed for COVID-19 antibody tests, after all the appropriate requirements are met in the first half of In 2021 in addition to the COVID-19 testing products and services, the company's top priority continues to be the commercialization of cancer screening tests and a medical device, that is, Cancer Differentiation Analysis (CDA) technology, with the business of registering Class A medical device products The third CDA active in China And validation of the CDA test as a developed laboratory test (LDT) in the United States, CEO of AnPac ​​Bio, D. Chris Yu commented: “The successful validation and commercialization of the COVID-19 antibody test in our laboratory in San Jose is a milestone. It indicates that AnPac ​​Bio has entered the commercialization and revenue generation phase in the United States moreover, with the addition of the much larger Philadelphia lab (once verified in the laboratory) planned for both COVID-19 antibody tests and CDA detection tests. Cancer (Once the LDT test is approved), we will accelerate marketing and revenue growth in the US About AnPac ​​BioAnPac ​​Bio is a biotech company focused on early detection and detection of cancer, with 128 patents issued as of June 30, 2020 through Two accredited clinical laboratories in China and a CLIA and CAP accredited clinical laboratory and a CLIA registered clinical laboratory in the United States, AnPac ​​Bio performs a range of cancer detection and detection tests, including CDA (Cancer Differentiation Analysis) and Biochemistry, Immunological Tests and Genomics According to Frost & Sullivan, AnPac ​​Bio is ranked third in the world and first in China among companies offering the next generation of early detection and detection technology for cancer in terms of the number of clinical samples for cancer screening and detection, based on nearly 41,700 Clinical sample as in May 2020 AnPac ​​Bio's CDA technology platform has been shown in retrospective verification studies to be able to detect risks of more than 20 different types of cancer with high sensitivity and specificity For more information, please visit: https://wwwAnpacbio.com for investor inquiries And the media, please contact: Company: Phil Case, Marketing and Investor Relations Tel: 1-267-810-6776 (United States) Email: phil_case @ AnPacbiocomInvestor Relations: Ascent Investor Relations LLC Tina Xiao, President's Phone: 1-917-609 -0333 (United States) Email: tina xiao@ascent-ircom Safe Harbor Statement - This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act 1933 and MA Article 21 of the Securities Law of 1934 These forward-looking statements were prepared in accordance with the provisions of the "safe harbor" of the Securities Litigation Reform Act 1995 and relate to the future financial and operational performance of the company. The company attempted to define forward-looking statements through terms including "believed," " Estimates, “Expect”, “Expect”, “Plans”, “Projects”, “Intent”, “Potential”, “Objective”, “Objective”, “Forecast”, “Expectations”, “Research”, “Objective”, Objective, Assumption, Thinking, Continuation, Situation, Prediction, Probability, May, May, May, Will, Should, or Approximately "Or other words that convey uncertainty about future events or outcomes to determine these forward-looking statements. These statements are based on current expectations, assumptions and uncertainties involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, which are difficult or impossible to predict." Accurately, many of them are outside the company’s control. This data also includes known and unknown risks, uncertainties and other factors that may cause it to be Actual company results are materially different from those expressed or implied through any forward-looking statement that includes known and unknown risks, uncertainties and other factors, including but not limited to the implementation of our business model and our growth strategies; Trends and competition in the cancer screening market; Our expectations regarding the demand and market acceptance of our cancer screening and detection tests and our ability to expand our client base; Our ability to obtain and maintain intellectual property protection for our CDA technology and our continuous research and development to keep pace with technological developments; Our ability to obtain and maintain regulatory approvals from the relevant NMPA, FDA, and U.S states that our laboratories are accredited or accredited by authorities including the CLIA; Developing our future business, financial condition, results of operations, and ability to obtain cost-effective financing; Potential changes to government regulations; General economic and trade conditions in China and elsewhere; Our ability to recruit and maintain key employees; Our relationship with our partners and major clients; The duration of the outbreak of the Coronavirus and its potential negative impact on economic conditions, financial markets, our business and our financial performance, such as the result of reduced commercial activities due to quarantine and travel restrictions imposed by China, Q and many other countries around the world to contain the spread of the virus In addition, all forward-looking statements are subject to "Risk Factors" detailed from time to time in the Company's most recent annual report in Form 20-F and other filings with the US Securities and Exchange Commission due to these and other risks, uncertainties and assumptions, should not be relied unnecessarily on these forward-looking statements. In addition, These statements are only spoken as of the date of this press release, and except as may be required by law, the company does not undertake any obligation to review or update any forward-looking statements publicly for any reason.

The company expects the CE mark to improve the accessibility of personal devices to become more easily available 3D printed CMF titanium implant from Materialize 10, 2020 (GLOBE NEWSWIRE) - Materialize NV (Nasdaq: MTLS), a leader in 3D technology solutions in the industrial and medical markets, announced that it has received CE Marking for most orthopedic and maxillofacial (CMF) procedures. 3D printed anatomical models, surgical guides and patient compatible implants, MATRIALIZ is a leading and world leader in personalized solutions, helping patients and surgeons on six continents produce more than 350The company became one of the first companies to obtain this kind of certification for a wide range of 3D printed medical devices This certification will make technology more accessible to surgeons CE approval indicates that the medical device meets the requirements of the European Medical Devices Directive So far, Materialise's custom devices have benefited from The specially designed procedure, which requires a prescription for each device This procedure guarantees the quality of the devices and the safety of the patients, but brings administrative obstacles to the production in greater quantities “When the European Medical Devices Directive was issued in 1993, the use of personal devices was exceptional in the past 30 years, we developed the planning And 3D printing to extend this technology to a much larger audience at Materialize, we're talking about thousands of devices being delivered around the world each year.Personal devices are no longer the exception This CE marking certification demonstrates that these personal devices meet the same stringent quality requirements as regular devices. , Despite the challenges involved in making each device match the specific anatomy of a patient, ”she says Well Brigitte De Witt, Vice President and Managing Director of Matrials Medic, Materialize has a legacy of adhering to the highest possible safety standards and is one of the first companies to have a complete personal portfolio CE certified. The company believes that this type of certification will help raise the bar in the industry to ensure safety. Patients and transparency in personal device production The CE marking will also improve accessibility to make personal devices more easily available With the implementation of the new process, surgeons will not need to sign a prescription for the devices they request, which means less paperwork and more flexibility for pharmacists who manage personal devices within the hospital. “The advantage of using dedicated devices is that it adds more predictability in the surgical setting and allows to treat any clinical condition, including the most difficult cases Now, obtaining this CE mark for our larger business portfolio will help in providing these personal devices to a greater number of patients, removing Some administrative limitations for our clients, ”Brigitte adds. Since its founding in 1990, custom solutions have been the core business of a company Realize Medical begins with customization with planning, the launch of Mimics software in 1992 enabled precision engineering based on 3D images, which formed the basis for the advanced digital planning solutions available today. Materialize was also the first company to introduce custom 3D printing solutions in the operating room with the launch of surgical knee guides In 2007 the launch of the personal CMF implant in 2009 introduced a design breakthrough with a porous structure of titanium that allowed rebuilding of lost bone fragments This CE certification is another milestone in achieving higher quality standards in personalized medicine Although the CE marking is a European concept, the system Widely accepted as proof of compliance in other markets This certification joins other CE marks that Materialize has already obtained on medical software solutions, such as Mimics Innovation Suite and Mimics Enlight on Materialize that integrates more than three decades of 3D printing experience into a range of solutions The software and 3D printing services, which together form the backbone of the 3D printing industry, enable open and flexible Materialise solutions Players in a wide range of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, from creating innovative 3D printing applications aiming to make the world a better and healthier place. Materiales is headquartered in Belgium, with branches around the world, and brings together Among the largest group of software developers in the industry and one of the largest 3D printing facilities in the world For additional information, please visit: www verified com L-101478-01 Attachments * MaterialiseCMFimplant * Femur_01 Contact: Bram Smits Embodiment Press @ Tjsdcom